Two selection criteria (i.e., numerical threshold and participant group): | |
Adverse events are reported if they occurred in ≥ 5% of participants in any intervention group. | |
Adverse events are reported if they occurred in ≥ 2% of participants receiving gabapentin. | |
Three selection criteria: | |
Adverse events are reported if they occurred in ≥ 2% of participants receiving gabapentin and if they occurred at least twice as frequently in participants receiving gabapentin, compared with participants receiving placebo. |